Extrahepatic metastasis of hepatocellular carcinoma: Incidence and risk factors

Liver International

Volumn 28, Issue 9, 2008, Pages 1256-1263

  Kanda, Miho ^a,b   Tateishi, Ryosuke ^a   Yoshida, Haruhiko ^a   Sato, Takahisa ^a   Masuzaki, Ryota ^a   Ohki, Takamasa ^a   Imamura, Jun ^b   Goto, Tadashi ^a   Yoshida, Hideo ^a   Hamamura, Keisuke ^a   Obi, Shuntaro ^b   Kanai, Fumihiko ^a   Shiina, Shuichiro ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Kyoundo Hospital   (Japan)

Author keywords

Disease free survival; Hepatocellular carcinoma; Interventional radiology; Tumour markers

Indexed keywords

ANTINEOPLASTIC AGENT; TUMOR MARKER;

ABDOMINAL RADIOGRAPHY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER INVASION; CANCER RISK; CATHETER ABLATION; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE MARKER; EXTRAHEPATIC METASTASIS; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; RECURRENCE RISK; TUMOR VOLUME; VIRUS HEPATITIS;

ADRENAL GLAND NEOPLASMS; AGED; BONE NEOPLASMS; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 51649125242     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01864.x     Document Type: Article

References (44)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Shiratori Y, Shiina S, Imamura M, et al. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan. Hepatology 1995; 22(Part 1): 1027-33.
3. Shiratori Y, Yoshida H, Omata M. Management of hepatocellular carcinoma: advances in diagnosis, treatment and prevention. Expert Rev Anticancer Ther 2001; 1: 277-90.
4. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-9.
5. Shapiro RS, Katz R, Mendelson DS, Halton KP, Schwartz ME, Miller CM. Detection of hepatocellular carcinoma in cirrhotic patients: Sensitivity of CT and ultrasonography. J Ultrasound Med 1996; 15: 497-502; quiz 03-4.
6. Spreafico C, Marchiano A, Mazzaferro V, et al. Hepatocellular carcinoma in patients who undergo liver transplantation: Sensitivity of CT with iodized oil. Radiology 1997; 203: 457-60.
7. Peterson MS, Baron RL, Marsh JW Jr, Oliver JH III, Confer SR, Hunt LE. Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: Epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation. Radiology 2000; 217: 743-9.
8. Stoker J, Romijn MG, De Man RA, et al. Prospective comparative study of spiral computer tomography and magnetic resonance imaging for detection of hepatocellular carcinoma. Gut 2002; 51: 105-7.
9. Arii S, Yamaoka Y, Futagawa S, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000; 32: 1224-9.
10. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35: 1164-71.
11. Shiina S, Teratani T, Obi S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129: 122-30.
12. Shiina S, Tagawa K, Niwa Y, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: Results in 146 patients. Am J Roentgenol 1993; 160: 1023-8.
13. Ikeda K, Saitoh S, Tsubota A, et al. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 1993; 71: 19-25.
14. Okada S, Shimada K, Yamamoto J, et al. Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 1994; 106: 1618-24.
15. Koike Y, Shiratori Y, Sato S, et al. Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus - an analysis of 236 consecutive patients with a single lesion. Hepatology 2000; 32: 1216-23.
16. Johnson RC. Hepatocellular carcinoma. Hepatogastroenterology 1997; 44: 307-12.
17. Edmondson HA, Steiner PE. Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies. Cancer 1954; 7: 462-503.
18. Anthony PP. Primary carcinoma of the liver: A study of 282 cases in Ugandan Africans. J Pathol 1973; 110: 37-48.
19. Aramaki M, Kawano K, Kai T, et al. Treatment for extrahepatic metastasis of hepatocellular carcinoma following successful hepatic resection. Hepatogastroenterology 1999; 46: 2931-4.
20. Lo CM, Lai EC, Fan ST, Choi TK, Wong J. Resection for extrahepatic recurrence of hepatocellular carcinoma. Br J Surg 1994; 81: 1019-21.
21. Lam CM, Lo CM, Yuen WK, Liu CL, Fan ST. Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma. Br J Surg 1998; 85: 1198-200.
22. Uka K, Aikata H, Takaki S, et al. Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. World J Gastroenterol 2007; 13: 414-20.
23. Kaczynski J, Hansson G, Wallerstedt S. Metastases in cases with hepatocellular carcinoma in relation to clinicopathologic features of the tumor. An autopsy study from a low endemic area. Acta Oncol 1995; 34: 43-8.
24. Katyal S, Oliver JH III, Peterson MS, Ferris JV, Carr BS, Baron RL Extrahepatic metastases of hepatocellular carcinoma. Radiology 2000; 216: 698-703.
25. Omata M, Tateishi R, Yoshida H, Shiina S. Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation. Gastroenterology 2004; 127(Suppl. 1): S159-66.
26. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457-81.
27. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-506.
28. Cox DR. Regression models and life-tables (with discussion). J R Stat Soc 1972; 34B: 187-220.
29. Ikai I, Arii S, Okazaki M, et al. Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res 2007; 37: 676-91.
30. Natsuizaka M, Omura T, Akaike T, et al. Clinical features of hepatocellular carcinoma with extrahepatic metastases. J Gastroenterol Hepatol 2005; 20: 1781-7.
31. Kondo Y, Niwa Y, Akikusa B, Takazawa H, Okabayashi A. A histopathologic study of early hepatocellular carcinoma. Cancer 1983; 52: 687-92.
32. Onuigbo WI. Batson's theory of vertebral venous metastasis: A review. Oncology 1975; 32: 145-50.
33. Batson OV. The function of the vertebral veins and their role in the spread of metastases. 1940. Clin Orthop Relat Res 1995; 4-9.
34. Yamashita N, Fukawa M, Imaizumi N, et al. Establishing a diagnosis of adrenal metastasis from hepatocellular carcinoma by 99mTc-PMT hepatobiliary scintigraphy. Surg Today 1992; 22: 565-7.
35. Momoi H, Shimahara Y, Terajima H, et al. Management of adrenal metastasis from hepatocellular carcinoma. Surg Today 2002; 32: 1035-41.
36. Zeng ZC, Tang ZY, Fan J, et al. Radiation therapy for adrenal gland metastases from hepatocellular carcinoma. Jpn J Clin Oncol 2005; 35: 61-7.
37. Sala M, Llovet JM, Vilana R, et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004; 40: 1352-60.
38. Iwata M, Kaneko S, Terasaki S, et al. Importance of achieving complete necrosis during the first treatment for hepatocellular carcinoma to prevent bone metastasis: A prospective study. J Gastroenterol Hepatol 2001; 16: 46-51.
39. Louha M, Poussin K, Ganne N, et al. Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer. Hepatology 1997; 26: 998-1005.
40. Sheen IS, Jeng KS, Shih SC, et al. Does surgical resection of hepatocellular carcinoma accelerate cancer dissemination? World J Gastroenterol 2004; 10: 31-6.
41. Lin SC, Shih SC, Kao CR, Chou SY. Transcatheter arterial embolization treatment in patients with hepatocellular carcinoma and risk of pulmonary metastasis. World J Gastroenterol 2003; 9: 1208-11.
42. Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985; 56: 918-28.
43. The Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients. Hepatology 1998; 28: 751-5.
44. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: The BCLC staging classification. Semin Liver Dis 1999; 19: 329-38.